These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 29052094)
1. Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Olteanu C; Shear NH; Chew HF; Hashimoto R; Alhusayen R; Whyte-Croasdaile S; Finkelstein Y; Burnett M; Ziv M; Sade S; Jeschke MG; Dodiuk-Gad RP Drug Saf; 2018 Mar; 41(3):277-284. PubMed ID: 29052094 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study. Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410 [TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Assessment of Long-Term Complications in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Cekic S; Canitez Y; Yuksel H; Ucan Gunduz G; Karali Z; Yalcinbayir O; Vural P; Sapan N Int Arch Allergy Immunol; 2023; 184(10):994-1002. PubMed ID: 37494888 [TBL] [Abstract][Full Text] [Related]
4. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up. Lee HY; Walsh SA; Creamer D Br J Dermatol; 2017 Oct; 177(4):924-935. PubMed ID: 28144971 [TBL] [Abstract][Full Text] [Related]
5. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. De Rojas MV; Dart JK; Saw VP Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145 [TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications. Ueta M Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311 [No Abstract] [Full Text] [Related]
7. Complications of Stevens-Johnson syndrome beyond the eye and skin. Saeed H; Mantagos IS; Chodosh J Burns; 2016 Feb; 42(1):20-27. PubMed ID: 25865527 [TBL] [Abstract][Full Text] [Related]
8. Physical and Psychological Recovery Following Toxic Epidermal Necrolysis: A Patient Survey. DeNiro KL; Honari S; Hippe DS; Dai A; Pham TN; Caceres M; Mandell SP; Duong PQ; McMullen KA; Gibran NS J Burn Care Res; 2021 Nov; 42(6):1227-1231. PubMed ID: 34105730 [TBL] [Abstract][Full Text] [Related]
9. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN. Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260 [TBL] [Abstract][Full Text] [Related]
13. Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Saito K; Ueta M; Maekawa K; Sotozono C; Kinoshita S; Saito Y PLoS One; 2016; 11(11):e0167402. PubMed ID: 27898730 [TBL] [Abstract][Full Text] [Related]
14. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series. Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534 [TBL] [Abstract][Full Text] [Related]
15. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis. Sato S; Kanbe T; Tamaki Z; Furuichi M; Uejima Y; Suganuma E; Takano T; Kawano Y Pediatr Int; 2018 Aug; 60(8):697-702. PubMed ID: 29888432 [TBL] [Abstract][Full Text] [Related]
16. Severe Dry Eye With Combined Mechanisms is Involved in the Ocular Sequelae of SJS/TEN at the Chronic Stage. Sotozono C; Ueta M; Yokoi N Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES80-DES86. PubMed ID: 30481810 [TBL] [Abstract][Full Text] [Related]
17. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases]. Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593 [TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601 [TBL] [Abstract][Full Text] [Related]
19. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402 [TBL] [Abstract][Full Text] [Related]
20. Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Chi MH; Chung WH; Hui RC; Chen CB; Lu CW; Chiu TM; Ma DH; Wang CW; Yang CY; J Dermatol; 2022 Sep; 49(9):895-902. PubMed ID: 35715971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]